Abstract:Herein, the exploration of natural plant‐based “spores” for the encapsulation of macromolecules as a drug delivery platform is reported. Benefits of encapsulation with natural “spores” include highly uniform size distribution and materials encapsulation by relatively economical and simple versatile methods. The natural spores possess unique micromeritic properties and an inner cavity for significant macromolecule loading with retention of therapeutic spore constituents. In addition, these natural spores can be… Show more
“…The observed rapid BSA release is attributed to the passage of molecules through the nanopores and micron‐sized apertures in the surface of SECs. A similar release profile was reported from natural sunflower ( H. annuus ) pollen grains and L. clavatum SECs in SGF and SIF …”
Section: Resultssupporting
confidence: 82%
“…To optimize loading and elucidate the loading distribution of dried compounds within SECs, BSA loading into sunflower SECs was evaluated for three different initial BSA‐loading proportions, 23, 37.5, and 54.5 wt%. The loading process involves applying a vacuum to the SEC–BSA suspension leading to a reduction in the internal cavity pressure, which in turn applies a force drawing the BSA solution into the hollow SECs …”
Section: Resultsmentioning
confidence: 99%
“…So far, SECs have been explored for the encapsulation of proteins and it is suggested that their mechanical and chemical durability may facilitate the oral delivery of proteins . Interestingly, enzymes encapsulated into Lycopodium clavatum SECs have been shown to retain their functionality following their release from the SECs, thus implying the protective nature of SECs toward encapsulated proteins .…”
Efficient oral administration of protein-based therapeutics faces significant challenges due to degradation from the highly acidic conditions present in the stomach and proteases present in the digestive tract. Herein, investigations into spike-covered sunflower sporopollenin exine capsules (SECs) for oral protein delivery using bovine serum albumin (BSA) as a model drug are reported and provide significant insights into the optimization of SEC extraction, SEC loading, and controlled release. The phosphoric-acid-based SEC extraction process is optimized. Compound loading is shown to be driven by the evacuation of air bubbles from SEC cavities through the porous SEC shell wall, and vacuum loading is shown to be the optimal loading method. Three initial BSA-loading proportions are evaluated, leading to a practical loading efficiency of 22.3 ± 1.5 wt% and the determination that the theoretical maximum loading is 46.4 ± 2.5 wt%. Finally, an oral delivery formulation for targeted intestinal delivery is developed by tableting BSA-loaded SECs and enteric coating. BSA release is inhibited for 2 h in simulated gastric conditions followed by 100% release within 8 h in simulated intestinal conditions. Collectively, these results indicate that sunflower SECs provide a versatile platform for the oral delivery of therapeutics.
“…The observed rapid BSA release is attributed to the passage of molecules through the nanopores and micron‐sized apertures in the surface of SECs. A similar release profile was reported from natural sunflower ( H. annuus ) pollen grains and L. clavatum SECs in SGF and SIF …”
Section: Resultssupporting
confidence: 82%
“…To optimize loading and elucidate the loading distribution of dried compounds within SECs, BSA loading into sunflower SECs was evaluated for three different initial BSA‐loading proportions, 23, 37.5, and 54.5 wt%. The loading process involves applying a vacuum to the SEC–BSA suspension leading to a reduction in the internal cavity pressure, which in turn applies a force drawing the BSA solution into the hollow SECs …”
Section: Resultsmentioning
confidence: 99%
“…So far, SECs have been explored for the encapsulation of proteins and it is suggested that their mechanical and chemical durability may facilitate the oral delivery of proteins . Interestingly, enzymes encapsulated into Lycopodium clavatum SECs have been shown to retain their functionality following their release from the SECs, thus implying the protective nature of SECs toward encapsulated proteins .…”
Efficient oral administration of protein-based therapeutics faces significant challenges due to degradation from the highly acidic conditions present in the stomach and proteases present in the digestive tract. Herein, investigations into spike-covered sunflower sporopollenin exine capsules (SECs) for oral protein delivery using bovine serum albumin (BSA) as a model drug are reported and provide significant insights into the optimization of SEC extraction, SEC loading, and controlled release. The phosphoric-acid-based SEC extraction process is optimized. Compound loading is shown to be driven by the evacuation of air bubbles from SEC cavities through the porous SEC shell wall, and vacuum loading is shown to be the optimal loading method. Three initial BSA-loading proportions are evaluated, leading to a practical loading efficiency of 22.3 ± 1.5 wt% and the determination that the theoretical maximum loading is 46.4 ± 2.5 wt%. Finally, an oral delivery formulation for targeted intestinal delivery is developed by tableting BSA-loaded SECs and enteric coating. BSA release is inhibited for 2 h in simulated gastric conditions followed by 100% release within 8 h in simulated intestinal conditions. Collectively, these results indicate that sunflower SECs provide a versatile platform for the oral delivery of therapeutics.
“…Being the first line of defense, sporopollenin is equipped with various evolutionary-driven resilient properties specifically tailored for protection and endurance to stay viable for extended lengths of time. Due to these attractive properties along with a large and renewable supply, pollen grains have gained the attention of the wider scientific community and are proving to be excellent microcapsules for encapsulation applications31617. In order to address possible issues of biocompatibility and allergenicity, a protein-free microcapsule derivative known as a sporopollenin exine capsule (SEC) was developed through an extraction process that leaves only the hollow sporopollenin exine layer, which itself functions as a microcapsule and can be utilized for encapsulation applications151819202122.…”
mentioning
confidence: 99%
“…However, current efforts have been focused on pollen or spores from only a small subset of plant species including Lycopodium clavatum 3151719222324 and Helianthus annus 16. Indeed, SEC process development has been limited to micrometer thick-walled pollen species with high mechanical stability which facilitates successful preservation of microarchitecture features throughout the harsh processing steps.…”
Sporopollenin is a physically robust and chemically resilient biopolymer that comprises the outermost layer of pollen walls and is the first line of defense against harsh environmental conditions. The unique physicochemical properties of sporopollenin increasingly motivate the extraction of sporopollenin exine capsules (SECs) from pollen walls as a renewable source of organic microcapsules for encapsulation applications. Despite the wide range of different pollen species with varying sizes and wall thicknesses, faithful extraction of pollen-mimetic SECs has been limited to thick-walled pollen capsules with rigid mechanical properties. There is an unmet need to develop methods for producing SECs from thin-walled pollen capsules which constitute a large fraction of all pollen species and have attractive materials properties such as greater aerosol dispersion. Herein, we report the first successful extraction of inflated SEC microcapsules from a thin-walled pollen species (Zea mays), thereby overcoming traditional challenges with mechanical stability and loss of microstructure. Morphological and compositional characterization of the SECs obtained by the newly developed extraction protocol confirms successful protein removal along with preservation of nanoscale architectural features. Looking forward, there is excellent potential to apply similar strategies across a wide range of unexplored thin-walled pollen species.
Playing an instrumental role in the life of plants, pollen microparticles are one of the most fascinating biological materials in existence, with abundant and renewable supply, ultrahigh durability, and unique, species-specific architectural features. Aside from their biological role, pollen microparticles also demonstrate broad utility as functional materials for drug delivery and microencapsulation, and increasingly for emulsion-type applications. As natural pollen microparticles are predominantly hydrophobic, developing robust surface functionalization strategies to increase surface hydrophilicity would increase the range of colloidal science applications, including opening the door to interfacing microparticles with biological cells. This research investigates the extraction and light-induced surface modification of discrete pollen microparticles from bee-collected pollen granules toward achieving functional control over the responses elicited from discrete particles in colloidal science and cellular applications. Ultravioletozone treatment is shown to increase the proportion of surface elemental oxygen and ketones, leading to increased surface hydrophilicity, enhanced particle dispersibility, tunable control over Pickering emulsion characteristics, and enhanced cellular adhesion. In summary, the findings demonstrate that light-induced surface modification improves the functional properties of pollen microparticles, and such insights also have broad implications across materials science and environmental science applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.